Outcome: Dismissed
JUN102024_05B5203
Our summary
Pharmaceutical and healthcare consultant sought EB-2 with national interest waiver to provide professional advice through independent consultancy. AAO dismissed appeal, finding proposed endeavor lacked national importance; insufficient evidence of broader field implications or substantial positive economic effects beyond individual clients.
Official PDF
Official PDF ↗Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.
No criterion in the table was found met in this decision.
What was missing
- Merit and national importance · Proposed pharmaceutical and healthcare consultancy lacks national importance; benefits limited to selected clients without broader implications.
Criteria
| Criterion | Reading | Why |
|---|---|---|
| Not met | Proposed pharmaceutical and healthcare consultancy lacks national importance; benefits limited to selected clients without broader implications. | |
| Not reached / not discussed | First prong failed; second prong not analyzed as dispositive issue reached. | |
| Not reached / not discussed | First prong failed; third prong not analyzed as dispositive issue reached. |
A published decision describes one case. It is not legal advice and not a prediction for yours.
